Skip to content

Clinical trials

Phase 3 Eye Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eye Diseases Phase: Phase 3 Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20162
20181
20191
20202
20213
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GenSight Biologics3
Kodiak Sciences Inc2
AbbVie1
Bayer1
King's College Hospital NHS Trust1
Laboratoires Thea1
Luigi Rondas1
Novartis Pharmaceuticals1
Opthea Limited1
Vanda Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases13
Retinal Diseases8
Retinal Degeneration5
Vision Disorders5
Eye Diseases, Hereditary4
Macular Degeneration4
Nervous System Diseases4
Optic Atrophy, Hereditary, Leber4
Wet Macular Degeneration4
Blindness3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.